Flurothyl

Short description: Chemical compound

Flurothyl

Clinical data
Other names| Hexafluorodiethyl ether
ATC code|

* None

Identifiers

IUPAC name

* 2,2-Oxybis(1,1,1-trifluoroethane)

Bis(2,2,2-trifluoroethyl) ether

CAS Number|

* 333-36-8 Y

PubChem CID|

* 9528

DrugBank|

* DB08969 N

ChemSpider|

* 9155 N

UNII|

* 9Z467FG2YK

Chemical and physical data
Formula| C4H4F6O
Molar mass| 182.064 g·mol−1
3D model (JSmol)|

* Interactive image

Density| 1.404 g/cm3 g/cm3
Boiling point| 62 to 63 °C (144 to 145 °F)

SMILES

* C(C(F)(F)F)OCC(F)(F)F

InChI

* InChI=1S/C4H4F6O/c5-3(6,7)1-11-2-4(8,9)10/h1-2H2 N

* Key:KGPPDNUWZNWPSI-UHFFFAOYSA-N N

NY (what is this?) (verify)

Flurothyl (Indoklon) (IUPAC names: 1,1,1-trifluoro-2-(2,2,2-trifluoroethoxy)ethane or bis(2,2,2-trifluoroethyl) ether) is a volatile liquid drug from the halogenated ether family, related to inhaled anaesthetic agents such as diethyl ether, but having the opposite effects, acting as a stimulant and convulsant.[1] A clear and stable liquid, it has a mild ethereal odor whose vapors are non-flammable. It is excreted from the body by the lungs in an unchanged state.[2][3][4]

Several compounds related to the halogenated ether anesthetics have similar convulsant effects rather than producing sedation, and this has been helpful in studying the mechanism of action of these drugs.[5][6][7]

Currently, the main uses of flurothyl are:

(1) scientific research for inducing seizures in laboratory animals;[8]

(2) as an additive in lithium-ion batteries. [9]

## Contents

* 1 Research into psychiatric treatment
* 2 Mechanism of Action
* 3 See also
* 4 References

## Research into psychiatric treatment

Flurothyl was at one time studied in psychiatric medicine for shock therapy, in a similar manner to other convulsant drugs such as pentetrazol, as an alternative to electroconvulsive therapy (ECT).[10][11] This use has now been discontinued.

In 1953, the Maryland pharmacologist J. C. Krantz experimented with flurothyl to induce seizures in psychiatric patients as an alternative to ECT. Flurothyl was injected into a plastic container in a tight fitting face mask. The patient inhaled a mixture of vapor and air, and expired air was forced into a charcoal adsorbent via a one-way valve. Oxygen was administered simultaneously. Flurothyl inhalations were first conducted without sedation or muscle paralysis.[12][13] Premedication with pentothal and succinylcholine chloride, as is customary in ECT, was tested and found safe.[14]

Four random assignment treatment studies found the clinical results for flurothyl to be as effective as those of ECT.[15][16][17][18] Flurothyl treatments were administered on the same schedules as ECT. In some patients who had not responded to ECT, flurothyl treatment produced improvement.[19]

The flurothyl treated patients showed less amnesia and confusion during the course of treatment with better patient acceptance. A detailed study comparing flurothyl and ECT in patients with severe endogenous depression, reported the degree of anterograde amnesia to be similar, but the degree of retrograde amnesia was much lower after flurothyl.[18] Psychological tests showed memory impairments at the fourth week of treatment, and memory improvement two weeks after the last treatment, with no measurable differences between the treatments.

Equal degrees of EEG slow wave increases were recorded in flurothyl and electrical induced seizures.[20] Oximetric and ECG studies showed comparable heart rate increases with occasional rhythmic irregularities.[16]

Flurothyl induced seizures were deemed clinically equal to electrical seizures with lesser effects on cognition and memory. An editorial in the Journal of the American Medical Association in 1966 encouraged its use.[21]

An injectable form of flurothyl was formulated.[22] The clinical results were the same as with inhaled flurothyl.[23]

## Mechanism of Action

The convulsant properties of flurothyl pose a challenge to unifying theories of general anesthetics such as the Meyer-Overton hypothesis (see Theories of general anaesthetic action).[24][25] A variety of halogenated ethers (e.g., isoflurane, sevoflurane) and diethyl ether itself are general anesthetics, and flurothyl is a substituted diethyl ether. Even more strikingly, a structural isomer of flurothyl known as isoflurothyl (1,1,1,3,3,3-hexafluoro-2-methoxypropane) induces general anesthesia and not convulsions in mice and dogs.[26] Isoflurothyl differs from the widely used inhalational anesthetic sevoflurane by only a single fluorine atom (sevoflurane has an additional fluorine on the methyl group).

A molecular explanation for the difference between flurothyl and isoflurothyl was provided by electrophysiology studies that showed flurothyl was an antagonist (blocker) of neuronal GABAA receptors and had no effect on neuronal glycine receptors.[27] This receptor selectivity resembles that of the well-characterized GABAA receptor antagonist picrotoxin. Studies using recombinant GABAA and glycine receptors confirmed this activity profile and further showed that isoflurothyl behaved similar to other ether anesthetics in acting as a positive allosteric modulator of GABAA and glycine receptors.[28] There is some evidence that flurothyl may actually possess general anesthetic properties at high concentrations that are masked by the more potent convulsant action.[26]

## See also

* Theories of general anaesthetic action

## References

1. ↑ "Flurothyl (Indoklon). Experience with an inhalational convulsant agent". Anaesthesia 22 (3): 425–34. July 1967. doi:10.1111/j.1365-2044.1967.tb02765.x. PMID 4951597.
2. ↑ "Further clinical studies of hexafluorodiethyl ether convulsive treatments". Journal of Neuropsychiatry 3: 159–62. 1962. PMID 14453985.
3. ↑ "The synthesis, chemical and physical properties of Indoklon". Journal of Neuropsychiatry 4: 153–6. February 1963. PMID 13989984.
4. ↑ "Anesthesia LXX: effect of inert fluorinated agents on fluroxene and flurothyl". Anesthesia and Analgesia 46 (3): 271–4. 1967. doi:10.1213/00000539-196705000-00001. PMID 4381591.
5. ↑ "Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis". Anesthesia and Analgesia 79 (6): 1043–8. December 1994. doi:10.1213/00000539-199412000-00004. PMID 7978424.
6. ↑ "Polyhalogenated methyl ethyl ethers: solubilities and anesthetic properties". Anesthesia and Analgesia 88 (5): 1161–7. May 1999. doi:10.1213/00000539-199905000-00036. PMID 10320188.
7. ↑ "Hypothesis: volatile anesthetics produce immobility by acting on two sites approximately five carbon atoms apart". Anesthesia and Analgesia 88 (6): 1395–400. June 1999. doi:10.1213/00000539-199906000-00036. PMID 10357351.
8. ↑ "Effects of drugs acting on the GABA-benzodiazepine receptor complex on flurothyl-induced seizures in Mongolian gerbils". European Journal of Pharmacology 536 (3): 241–7. May 2006. doi:10.1016/j.ejphar.2006.02.036. PMID 16581068.
9. ↑ (76) Jiang, L. L.; Yan, C.; Yao, Y. X.; Cai, W.; Huang, J. Q.; Zhang, Q. Inhibiting Solvent Cointercalation in a Graphite Anode by a Localized High-Concentration Electrolyte in Fast-Charging Batteries. Angew. Chem., Int. Ed. 2021, 60, 3402−3406.
10. ↑ "A convulsant agent for psychiatric use. Flurothyl (Indoklon)". JAMA 196 (1): 29–30. April 1966. doi:10.1001/jama.196.1.29. PMID 4379572.
11. ↑ "A double-blind comparative evaluation of flurothyl and ECT". Archives of General Psychiatry 19 (1): 79–86. July 1968. doi:10.1001/archpsyc.1968.01740070081012. PMID 5658383.
12. ↑ "Hexafluorodiethyl ether (indoklon): its use as a convulsant in psychiatric treatment". The Journal of Nervous and Mental Disease 126 (6): 530–4. June 1958. doi:10.1097/00005053-195806000-00004. PMID 13564231.
13. ↑ "Hexafluorodiethyl ether (indoklon); an inhalant convulsant; its use in psychiatric treatment". Journal of the American Medical Association 166 (13): 1555–62. March 1958. doi:10.1001/jama.1958.02990130015004. PMID 13513394.
14. ↑ "Indoklon combined with Pentothal and Anectine". Am. J. Psychiatry 115 (11): 1041–1042. 1959. doi:10.1176/ajp.115.11.1041.
15. ↑ "Inhalant-induced convulsions. Significance for the theory of the convulsive therapy process". Archives of General Psychiatry 4 (3): 259–66. March 1961. doi:10.1001/archpsyc.1961.01710090045006. PMID 13699611.
16. ↑ 16.0 16.1 "A comparative study of hexafluorodiethyl ether (indoklon) and electroconvulsive therapy". The Journal of Nervous and Mental Disease 129: 95–8. July 1959. doi:10.1097/00005053-195907000-00016. PMID 14412877.
17. ↑ "A double-blind comparative evaluation of flurothyl and ECT". Archives of General Psychiatry 19 (1): 79–86. July 1968. doi:10.1001/archpsyc.1968.01740070081012. PMID 5658383.
18. ↑ 18.0 18.1 "Flurothyl convulsive therapy". Acta Psychiatrica Scandinavica. Supplementum 213: 1–79. 1970. PMID 4394881.
19. ↑ "The use of hexafluorodiethyl ether in psychiatric treatment". Journal of Neuropsychiatry 2: 67–70. 1960. PMID 13751512.
20. ↑ Convulsive Therapy: Theory and Practice.. New York: Raven Press. 1979.
21. ↑ "A convulsant agent for psychiatric use. Flurothyl (Indoklon)". JAMA 196 (1): 29–30. April 1966. doi:10.1001/jama.196.1.29. PMID 4379572.
22. ↑ "The availability of hexafluorodiethyl ether by intravenous injection as a convulsant in psychiatric treatment". The Journal of Nervous and Mental Disease 129: 92–4. July 1959. doi:10.1097/00005053-195907000-00015. PMID 14411701.
23. ↑ "Clinical experiences with intravenous Indoklon: a new convulsant drug". Journal of Neuropsychiatry 4: 184–9. February 1963. PMID 13962526.
24. ↑ "Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis". Anesthesia and Analgesia 79 (6): 1043–8. December 1994. doi:10.1213/00000539-199412000-00004. PMID 7978424.
25. ↑ "Contradicting a unitary theory of general anesthetic action: a history of three compounds from 1901 to 2001". Bulletin of Anesthesia History 21 (3): 1, 4-8, 21 passim. July 2003. doi:10.1016/s1522-8649(03)50031-2. PMID 17494361.
26. ↑ 26.0 26.1 "Are convulsant gases also anesthetics?". Anesthesia and Analgesia 60 (7): 464–70. July 1981. doi:10.1213/00000539-198107000-00002. PMID 7195661.
27. ↑ "Effects of two volatile anesthetics and a volatile convulsant on the excitatory and inhibitory amino acid responses in dissociated CNS neurons of the rat". Journal of Neurophysiology 66 (6): 2014–21. December 1991. doi:10.1152/jn.1991.66.6.2014. PMID 1667416.
28. ↑ "Differential modulatory actions of the volatile convulsant flurothyl and its anesthetic isomer at inhibitory ligand-gated ion channels". Neuropharmacology 39 (7): 1168–83. April 2000. doi:10.1016/s0028-3908(99)00221-x. PMID 10760360.

{{Navbox | name = GABA receptor modulators | title = GABA receptor modulators | state = collapsed | bodyclass = hlist | groupstyle = text-align:center;

| group1 = Ionotropic
|  list1 = {{Navbox|subgroup
| groupstyle = text-align:center
| groupwidth = 5em

| group1 = GABAA
| list1  =

* Agonists: (+)-Catechin
* Bamaluzole
* Barbiturates (e.g., phenobarbital)
* BL-1020
* DAVA
* Dihydromuscimol
* GABA
* Gabamide
* GABOB
* Gaboxadol (THIP)
* Homotaurine (tramiprosate, 3-APS)
* Ibotenic acid
* iso-THAZ
* iso-THIP
* Isoguvacine
* Isomuscimol
* Isonipecotic acid
* Kojic amine
* Lignans (e.g., honokiol)
* Methylglyoxal
* Monastrol
* Muscimol
* Nefiracetam
* Neuroactive steroids (e.g., allopregnanolone)
* Org 20599
* PF-6372865
* Phenibut
* Picamilon
* P4S
* Progabide
* Propofol
* Quisqualamine
* SL-75102
* TACA
* TAMP
* Terpenoids (e.g., borneol)
* Thiomuscimol
* Tolgabide
* ZAPA

* Positive modulators (abridged; see here for a full list): α-EMTBL
* Alcohols (e.g., ethanol)
* Anabolic steroids
* Avermectins (e.g., ivermectin)
* Barbiturates (e.g., phenobarbital)
* Benzodiazepines (e.g., diazepam)
* Bromide compounds (e.g., potassium bromide)
* Carbamates (e.g., meprobamate)
* Carbamazepine
* Chloralose
* Chlormezanone
* Clomethiazole
* Dihydroergolines (e.g., ergoloid (dihydroergotoxine))
* Etazepine
* Etifoxine
* Fenamates (e.g., mefenamic acid)
* Flavonoids (e.g., apigenin, hispidulin)
* Fluoxetine
* Flupirtine
* Imidazoles (e.g., etomidate)
* Kava constituents (e.g., kavain)<!--PMID: 9776662-->
* Lanthanum
* Loreclezole
* Monastrol
* Neuroactive steroids (e.g., allopregnanolone, [[Chemistry:Cholecholesterol]], THDOC)
* Niacin
* Nicotinamide (niacinamide)
* Nonbenzodiazepines (e.g., β-carbolines (e.g., [[abecarnil), cyclopyrrolones (e.g., zopiclone), imidazopyridines (e.g., zolpidem), pyrazolopyrimidines (e.g., zaleplon))
* Norfluoxetine
* Petrichloral
* Phenols (e.g., propofol)
* Phenytoin
* Piperidinediones (e.g., glutethimide)
* Propanidid
* Pyrazolopyridines (e.g., etazolate)
* Quinazolinones (e.g., methaqualone)
* Retigabine (ezogabine)
* ROD-188
* Skullcap constituents (e.g., baicalin)
* Stiripentol
* Sulfonylalkanes (e.g., sulfonmethane (sulfonal))
* Topiramate
* Valerian constituents (e.g., valerenic acid)
* Volatiles/gases (e.g., chloral hydrate, chloroform, [[Chemistry:Diethyl diethyl ether, Parparaldehyde]], sevoflurane)

* Antagonists: Bicuculline
* Coriamyrtin
* Dihydrosecurinine
* Gabazine (SR-95531)
* Hydrastine
* Hyenachin (mellitoxin)
* PHP-501
* Pitrazepin
* Securinine
* Sinomenine
* SR-42641
* SR-95103
* Thiocolchicoside
* Tutin

* Negative modulators: 1,3M1B
* 3M2B
* 11-Ketoprogesterone
* 17-Phenylandrostenol
* α5IA (LS-193,268)
* β-CCB
* β-CCE
* β-CCM
* β-CCP
* β-EMGBL
* Anabolic steroids
* Amiloride
* Anisatin
* β-Lactams (e.g., penicillins, cephalosporins, carbapenems)
* Basmisanil
* Bemegride
* Bicyclic phosphates (TBPS, TBPO, IPTBO)
* BIDN
* Bilobalide
* Bupropion
* CHEB
* Chlorophenylsilatrane
* Cicutoxin
* Cloflubicyne
* Cyclothiazide
* DHEA
* DHEA-S
* Dieldrin
* (+)-DMBB
* DMCM
* DMPC
* EBOB
* Etbicyphat
* FG-7142 (ZK-31906)
* Fiproles (e.g., fipronil)
* Flavonoids (e.g., amentoflavone, oroxylin A)
* Flumazenil
* Fluoroquinolones (e.g., ciprofloxacin)
* Flurothyl
* Furosemide
* Golexanolone
* Iomazenil (123I)
* IPTBO
* Isopregnanolone (sepranolone)
* L-655,708
* Laudanosine
* Leptazol
* Lindane
* MaxiPost
* Morphine
* Morphine-3-glucuronide
* MRK-016
* Naloxone
* Naltrexone
* Nicardipine
* Nonsteroidal antiandrogens (e.g., [[apalutamide, [[Chemistry:Bicalutbicalutamide, Enzalutenzalutamide, Chemistry:Flutamide|flut]]amide]], nilutamide)
* Oenanthotoxin
* Pentylenetetrazol (pentetrazol)
* Phenylsilatrane
* Picrotoxin (i.e., picrotin, picrotoxinin and dihydropicrotoxinin)
* Pregnenolone sulfate
* Propybicyphat
* PWZ-029
* Radequinil
* Ro 15-4513
* Ro 19-4603
* RO4882224
* RO4938581
* Sarmazenil
* SCS
* Suritozole
* TB-21007
* TBOB
* TBPS
* TCS-1105
* Terbequinil
* TETS
* Thujone
* U-93631
* Zinc
* ZK-93426

| group2 = GABAA-ρ
| list2  =

* Agonists: BL-1020
* CACA
* CAMP
* Homohypotaurine
* GABA
* GABOB
* Ibotenic acid
* Isoguvacine
* Muscimol
* N4-Chloroacetylcytosine arabinoside
* Picamilon
* Progabide
* TACA
* TAMP
* Thiomuscimol
* Tolgabide

* Positive modulators: Allopregnanolone
* Alphaxolone
* ATHDOC
* Lanthanides

* Antagonists: (S)-2-MeGABA
* (S)-4-ACPBPA
* (S)-4-ACPCA
* 2-MeTACA
* 3-APMPA
* 4-ACPAM
* 4-GBA
* cis-3-ACPBPA
* CGP-36742 (SGS-742)
* DAVA
* Gabazine (SR-95531)
* Gaboxadol (THIP)
* I4AA
* Isonipecotic acid
* Loreclezole
* P4MPA
* P4S
* SKF-97541
* SR-95318
* SR-95813
* TPMPA
* trans-3-ACPBPA
* ZAPA

* Negative modulators: 5α-Dihydroprogesterone
* Bilobalide
* Loreclezole
* Picrotoxin (picrotin, picrotoxinin)
* Pregnanolone
* ROD-188
* THDOC
* Zinc

| group2 = Metabotropic

| list2 =

GABAB|

* Agonists: 1,4-Butanediol
* 4-Fluorophenibut
* Aceburic acid
* Arbaclofen
* Arbaclofen placarbil
* Baclofen
* BL-1020
* GABA
* Gabamide
* GABOB
* GBL
* GHB
* GHBAL
* GHV
* GVL
* Isovaline
* Lesogaberan
* Phenibut
* Picamilon
* Progabide
* Sodium oxybate
* SKF-97,541
* SL 75102
* Tolgabide
* Tolibut

* Positive modulators: ADX-71441
* BHF-177
* BHFF
* BSPP
* CGP-7930
* CGP-13501
* GS-39783
* rac-BHFF
* KK-92A

* Antagonists: 2-Hydroxysaclofen
* CGP-35348
* CGP-46381
* CGP-52432
* CGP-54626
* CGP-55845
* CGP-64213
* DAVA
* Homotaurine (tramiprosate, 3-APS)
* Phaclofen
* Saclofen
* SCH-50911
* SKF-97541

* Negative modulators: Compound 14

|

| below =

See also
Receptor/signaling modulators
GABAA receptor positive modulators
GABA metabolism/transport modulators

* v
* t
* e

Convulsants

GABA receptor antagonists|

* Picrotoxin
* Gabazine
* Tetramethylenedisulfotetramine
* Cicutoxin
* Phenylsilatrane
* Tutin
* Pentylenetetrazol
* Thujone
* Endosulfan
* Bicuculline
* Oenanthotoxin
* Fipronil
* EBOB
* BIDN
* Dihydropicrotoxinin
* DMCM
* FG-7142
* Chlorophenylsilatrane
* Bicyclic phosphates (TBPS, TBPO, IPTBO)

GABA synthesis inhibitors|

* Allylglycine
* Crimidine
* Ginkgotoxin
* Toxopyrimidine
* Isoniazid
* 3-Mercaptopropionic acid
* 4-Deoxypyridoxine

Glycine receptor antagonists|

* Strychnine
* Tutin
* Picrotoxin
* Dendrobine

Glutamate receptor agonists|

* AMPA
* NMDA
* Kainic acid
* Domoic acid
* Quisqualic acid
* Tetrazolylglycine

Other|

* Methyl fluoroacetate
* Fluoroethyl fluoroacetate
* Nitrocyclohexane
* Methionine sulfoximine

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Flurothyl. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Flurothyl&oldid=825439"
*[CID]: Compound ID
*[GABA]: γ-Aminobutyric acid
*[GABAA]: γ-Aminobutyric acid A receptor
*[GABAA-ρ]: γ-Aminobutyric acid A-rho receptor
*[GABAB]: γ-Aminobutyric acid B receptor
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template